You are here: Industry Insights > Advanced Cancer

News List

Innovent and Shenogen Announce Collaboration to Evaluate Tyvyt® (Sintilimab injection) in Combination with SNG1005 for the Treatment of Patients with Advanced Cancer prnasia
August 06, 2019
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced the signing of a collaboration agreement with ...
Targeted drugs for advanced cancer move from specialist units to community setting worldpharmanews
October 19, 2018
Nearly 1 in 4 patients with advanced cancer, treated at Comprehensive Cancer Care Network (NCCN) centres in the US, are receiving innovative drugs matched to DNA mutations in their tumours.
NUS scientists harness AI platform for advanced cancer biospectrumasia
September 04, 2018
The new study demonstrates that CURATE.AI can optimize multi-drug regimens.
Athenex Announces the US FDA Allowance of the Investigational New Drug Application of Oratopo, A Com en-cphi.cn
March 29, 2017
Athenex, Inc. announced today that it has received United States Food and Drug Administration (US FDA) allowance to proceed into human clinical trials with the combination of oral topotecan and its proprietary P-glycoprotein (P-gp) inhibitor HM30181A.